Medscape Allergy ,

Incidence of Cardiovascular Events Doubled in MS Patients Incidence of Cardiovascular Events Doubled in MS Patients

Risk for major adverse cardiovascular events, including MI, stroke and cardiac arrest, was double that of patients without multiple sclerosis, new research suggests.Medscape Medical News (Source: Medscape Allergy Headlines)

Medscape Allergy Headlines

02:04

Some Rare Neuroendocrine Tumors May Respond to Ipilimumab Plus Nivolumab Some Rare Neuroendocrine Tumors May Respond to Ipilimumab Plus Nivolumab

Patients with fast-growing non-pancreatic neuroendocrine tumors may respond to combination therapy with ipilimumab plus nivolumab, according to findings within the Dual Anti-CTLA-4& Anti-PD-1 blockade in Rare Tumors (DART) trial.Reuters Health Information (Source: Medscape Allergy Headlines)

Medscape Allergy Headlines

Thu Mar 05, 2020 22:36

Imaging Study Reveals What Vaping Lung Injury Looks Like in Teens Imaging Study Reveals What Vaping Lung Injury Looks Like in Teens

Vaping-associated lung injury in teenagers is characterized by bilateral symmetric ground-glass opacities with subpleural sparing, consolidation and a lower-lobe predominance, according to the first study to examine both chest x-ray and CT imaging findings in this patient population.Reuters Health Information (Source: Medscape Allergy Headlines)

Medscape Allergy Headlines

Thu Mar 05, 2020 06:50

Lebrikizumab Safe, Effective Against Moderate-to-Severe Eczema in Mid-Stage Trial Lebrikizumab Safe, Effective Against Moderate-to-Severe Eczema in Mid-Stage Trial

The monoclonal antibody lebrikizumab was effective and generally well tolerated in adults with moderate-to-severe atopic dermatitis, a dose-ranging study reveals.Reuters Health Information (Source: Medscape Allergy Headlines)

Medscape Allergy Headlines

Wed Mar 04, 2020 23:00

Mark above section as read